SOX9 dysregulation has catastrophic effects on cartilage ECM composition, and the negative feedback loop leads to cartilage disease.[87, 88] CLCS treated cartilage did not show any significant differences in SOX9 expression in comparison to healthy cartilage, strongly suggesting a beneficial regenerative outcome induced by early immune modulation. The gene discussed is SOX9; the disease is cartilage disease.